home / stock / tlt:cc / tlt:cc news

TLT:CC News and Press, Theralase Technologies Inc. From 01/12/26

Stock Information
Company Name: Theralase Technologies Inc.
Stock Symbol: TLT:CC
Market: TSXVC
Website: theralase.com
Menu
TLT:CC TLT:CC Quote TLT:CC Short TLT:CC News TLT:CC Articles TLT:CC Message Board
Get TLT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
TLT:CC - Canadian Investment Regulatory Organization Trade Resumption - TLT

Canadian Investment Regulatory Organization Trade Resumption - TLT Canada NewsWire VANCOUVER, BC , Jan. 12, 2026 /CNW/ - Trading resumes in: Company: Theralase Technologies Inc. TSX-Venture Symbol: TLT All Issues: Yes Resumption (ET): 10:00 CIRO can make a dec...
TLT:CC - Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar ® (TLD-1433) in patients with Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer carcinoma in-situ with or w...

TLT:CC - Canadian Investment Regulatory Organization Trading Halt - TLT

Canadian Investment Regulatory Organization Trading Halt - TLT Canada NewsWire VANCOUVER, BC , Jan. 9, 2026 /CNW/ - The following issues have been halted by CIRO Company: Theralase Technologies Inc. TSX-Venture Symbol: TLT All Issues: Yes Reason: Pending News ...

TLT:CC - Theralase(R) Closes $1.3 M Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment ...
TLT:CC - Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatmen...

TLT:CC - Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study

Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer,...

TLT:CC - Theralase(R) Investor Conference Call Reminder

Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete Response Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (" Theralase® " or the " Company "), a c...
TLT:CC - Theralase(R) Releases 3Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. ( TSXV:TLT) (OTCQB:TLTFF ) (" Theralase® " or the " Company "), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer,...

TLT:CC - Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase ® Technologies Inc.  (TSXV: TLT) (OTCQB: TLTFF ) (" Theralase ® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatme...

TLT:CC - Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase ® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF)  (" Theralase ® " or the " Company "), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment ...
Previous 10 Next 10